☰

Shennan Lu, Ph.D. - Publications

Affiliations: 
2000 University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Area:
Molecular Biology, Oncology, Obstetrics and Gynecology, Pharmacology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Lu S, Benbrook DM. Role of AP-1 Antagonism in Growth Inhibition of Cervical Cancer Cell Lines by Retinoids American Journal of Pharmacology and Toxicology. 1: 40-47. DOI: 10.3844/Ajptsp.2006.40.47  0.615
2001 Simoni D, Roberti M, Invidiata FP, Rondanin R, Baruchello R, Malagutti C, Mazzali A, Rossi M, Grimaudo S, Capone F, Dusonchet L, Meli M, Raimondi MV, Landino M, D'Alessandro N, ... ... Lu S, et al. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells Journal of Medicinal Chemistry. 44: 2308-2318. PMID 11428925 DOI: 10.1021/Jm0010320  0.614
2000 Dhar A, Liu S, Klucik J, Berlin KD, Madler MM, Lu S, Ivey RT, Zacheis D, Brown CW, Nelson EC, Birckbichler PJ, Benbrook DM. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids Journal of Medicinal Chemistry. 43: 303. PMID 10650065  0.472
1999 Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. Journal of Medicinal Chemistry. 42: 4434-45. PMID 10543887 DOI: 10.1021/Jm990292I  0.614
1999 Dhar A, Liu S, Klucik J, Berlin KD, Madler MM, Lu S, Ivey RT, Zacheis D, Brown CW, Nelson EC, Birckbichler PJ, Benbrook DM. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids. Journal of Medicinal Chemistry. 42: 3602-14. PMID 10479291 DOI: 10.1021/Jm9900974  0.625
1999 Salsman S, Lu S, Benbrook DM. The mechanism of retinoic acid radiosensitization is independent of AP-1 repression in a cervical carcinoma cell line. Gynecologic Oncology. 73: 253-6. PMID 10329043 DOI: 10.1006/Gyno.1999.5352  0.621
1997 Benbrook DM, Madler MM, Spruce LW, Birckbichler PJ, Nelson EC, Subramanian S, Weerasekare GM, Gale JB, Patterson MK, Wang B, Wang W, Lu S, Rowland TC, DiSivestro P, Lindamood C, et al. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity. Journal of Medicinal Chemistry. 40: 3567-83. PMID 9357524 DOI: 10.1021/Jm970196M  0.63
1997 Benbrook DM, Lu S, Flanagan C, Shen-Gunther J, Angros LH, Lightfoot SA. Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells. Gynecologic Oncology. 66: 114-21. PMID 9234931 DOI: 10.1006/Gyno.1997.4736  0.611
Show low-probability matches.